The US compounding pharmacies market is expected to reach US$ 5,069.56 million by 2027 from US$ 3,079.64 million in 2019. The market is anticipated to grow at a CAGR of 6.5% from 2020 to 2027.
The growth of the market in the country is driven by the factors such as the drug shortage crisis in the US and benefits associated with compounded medications. However, product recalls and stringent regulatory requirements across the country are likely to hinder the compounding pharmacies market growth during the forecast period.
The US is encountering a rapid increase in drug shortage, which has caused various difficulties for health care facilities, clinicians, patients, and federal regulators. Many factors are involved in drug shortage, including challenges in manufacturing, acquisition of raw materials, regulatory issues, and business arrangements, as well as several other disruptions within the supply chain. According to the American Society of Health-System Pharmacists, drug shortages can negatively affect drug therapy and delay medical procedures resulting in medication errors. Drug shortages range from simple medicines, such as buffered aspirin, to life-saving medications—such as cancer antibiotics and cancer chemotherapy agents—and emergency medications, such as epinephrine. Healthcare professionals, especially pharmacists, along with the US government and drug manufacturers, are consistently working on managing this public-health crisis. Health care personnel have started to formulate solutions to a drug shortage. Compounding pharmacies are considered a viable source of drugs that are in short supply.
A compounding pharmacy or specialty pharmacy makes drugs recommended by doctors for patients that are not commercially available. The demand for compounding pharmacy is growing due to many benefits associated with it. For instance, compounding pharmacy is highly recommended to patients with allergies or to those who are very young and need a small dosage of a particular medication. Additionally, pharmacists can alter ingredients if patients are lactose intolerant, glucose intolerant, or allergic to the commercial drug's unnecessary dye. Moreover, pharmacists can lessen the dosage for children or can add flavor for children and double the dose for older adults depending on their needs. For patients who are delicate to oral administration, one can change pill formulation into a liquid for the ease of taking it. Compounding pharmacists can get access to medications that have been discontinued to patients who still depend on them. They can recreate the pharmaceutical-based ingredients to retain patients’ health.
Thus, drug shortage crisis in US and benefits associated with compounded medications are likely to propel the growth of the compounding pharmacy market in the U.S. during the forecast period.
US Compounding Pharmacies Market Revenue and Forecast to 2027 (US$ Million)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
US Compounding Pharmacies – Market Segmentation
By Product
- Oral Medications
- Topical Medications
- Suppositories
- Others
By Therapeutic Area
- Pain Medications
- Dermatological Applications
- Hormone Replacement Therapies
- Others
Company Profiles
- Fagron
- Triangle Compounding Pharmacy
- Institutional Pharmacy Solutions, LLC
- B. Braun Melsungen AG
- Pharmedium Services LLC
- Fresenius Kabi AG
- Avella Specialty Pharmacy
- Pencol Compounding Pharmacy
- Vertisis Custom Pharmacy
- US Compounding Inc.

Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
This text is related
to segments covered.

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
This text is related
to country scope.
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 US Compounding Pharmacies Market – By Product
1.3.2 US Compounding Pharmacies Market – By Therapeutic Area
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. US Compounding Pharmacies Market Landscape
4.1 Market Overview
4.2 PEST Analysis
4.2.1 US: PEST Analysis
4.3 Expert Opinion
5. US Compounding Pharmacies Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Drug Shortage Crisis in US
5.1.2 Benefits Associated with Compounded Medications
5.2 Market Restraints
5.2.1 Product Recalls and Stringent Regulatory Requirements
5.3 Market Opportunities
5.3.1 Growing Demand for Compounding Pharmacy During COVID-19
5.4 Future Trends
5.4.1 Growing Outsourcing Facilities for Manufacturing and Sales of Products
5.5 Impact Analysis
6. Compounding Pharmacies– US Market Analysis
6.1 US Compounding Pharmacies Market Overview
6.2 Market Positioning of Key Players
7. US Compounding Pharmacies Market Analysis– Product
7.1 Overview
7.2 US Compounding Pharmacies Market, by Product 2019 & 2027 (%)
7.3 Oral Medications
7.3.1 Overview
7.3.2 US Oral Medications Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Topical Medications
7.4.1 Overview
7.4.2 US Topical Medications Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Suppositories
7.5.1 Overview
7.5.2 US Suppositories Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Others
7.6.1 Overview
7.6.2 Others Market Revenue and Forecasts to 2027 (US$ Mn)
8. US Compounding Pharmacies Market Analysis – Therapeutic Area
8.1 Overview
8.2 US Compounding Pharmacies Market, By Therapeutic Area 2019 & 2027 (%)
8.3 Pain Medications
8.3.1 Overview
8.3.2 US Pain Medications Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Hormone Replacement Therapies
8.4.1 Overview
8.4.2 US Hormone Replacement Therapies Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Dermatological Applications
8.5.1 Overview
8.5.2 US Dermatological Applications Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Others
8.6.1 Overview
8.6.2 US Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. Impact of COVID-19 Pandemic on US Compounding Pharmacies Market
9.1 US: Impact Assessment of COVID-19 Pandemic
10. Industry Landscape
10.1 Overview
10.2 Growth Strategies Done by the Companies in the Market, (%)
10.3 Organic Developments
10.3.1 Overview
10.4 Inorganic Developments
10.4.1 Overview
11. Company Profiles
11.1 Fagron, Inc.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Triangle Compounding Pharmacy
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Institutional Pharmacy Solutions, LLC
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 B.Braun Melsungen AG
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 PharMEDium Healthcare Holdings, Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Fresenius Kabi AG
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Avella specialty pharmacy
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Pencol Compounding Pharmacy
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Vertisis Custom Pharmacy
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
1.44 US Compounding Inc.
1.44.1 Key Facts
1.44.2 Business Description
1.44.3 Products and Services
1.44.4 Financial Overview
1.44.5 SWOT Analysis
1.44.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. A few drugs that are in short supply are listed below:
Table 2. Organic Developments Done By Companies
Table 3. Inorganic Developments Done By Companies
Table 4. Glossary of Terms, US Compound Pharmacies Market
LIST OF FIGURES
Figure 1. US Compounding Pharmacies Market Segmentation
Figure 2. US Compounding Pharmacies Market Overview
Figure 3. Topical Medication is Expected to Show Remarkable Growth During Forecast Period
Figure 4. US Compounding Pharmacies Market, Industry Landscape
Figure 5. US: PEST Analysis
Figure 6. Expert Opinion
Figure 7. US Compounding Pharmacies Market Impact Analysis of Drivers and Restraints
Figure 8. Overview of US Compounding Pharmacies Market
Figure 9. Market Positioning Of Key Players In US Compounding Pharmacies Market
Figure 10. US Compounding Pharmacies Market, By Product 2019 & 2027 (%)
Figure 11. US Oral Medications Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. US Topical Medications Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. US Suppositories Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. US Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. US Compounding Pharmacies Market, by Therapeutic Area 2019 & 2027 (%)
Figure 16. US Pain Medications Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. US Hormone Replacement Therapies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. US Dermatological Applications Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. US Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Impact of COVID-19 Pandemic on Compounding Pharmacies Market in the US
Figure 21. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - US Compounding Pharmacies Market
- Fagron
- Triangle compounding pharmacy
- Institutional pharmacy solutions, llc
- B. Braun melsungen ag
- Pharmedium services llc
- Fresenius kabi ag
- Avella specialty pharmacy
- Pencol Compounding Pharmacy
- Vertisis custom pharmacy
- US Compounding Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.